OMX VENTURES, LLC
OMX VENTURES, LLC is a Seed and Series A fund in the US, United Kingdom and Europe writing $500K–$15M checks into AI, Healthcare, bioengineering, therapeutics, bio-tools, diagnostics, synthetic-biology and big-data.
- Stages
- Seed, Series A
- Sectors
- AI, Healthcare, bioengineering, therapeutics, bio-tools, diagnostics, synthetic-biology, big-data
- Check size
- $500K–$15M
- Invests in
- US-wide, United Kingdom, Europe
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $150M
Thesis
OMX Ventures is a venture capital firm established in 2020, specializing in early-stage investments within the bioengineering sector. Their investment thesis centers on identifying and scaling transformative discoveries at the convergence of biology, big data, and artificial intelligence, targeting significant unmet needs in large markets. The firm primarily focuses on Seed and Series A funding rounds, with key sectors of interest including therapeutics, bio-tools, diagnostics, and synthetic biology. Geographically, OMX Ventures invests across the United States, the United Kingdom, and Europe. Their first fund, OMX Ventures Fund I, closed oversubscribed in March 2021, raising over $150 million in committed capital. The fund is dedicated to supporting early-stage companies developing foundational research tools, instruments, therapeutic development platforms, and synthetic biology solutions. The typical investment size per deal ranges from $500,000 to $15 million.
Common questions
Does OMX VENTURES, LLC invest at the Seed stage?
Yes. OMX VENTURES, LLC lists Seed and Series A among the stages it invests in.
What check size does OMX VENTURES, LLC write?
OMX VENTURES, LLC writes $500K–$15M checks.
Where does OMX VENTURES, LLC invest?
OMX VENTURES, LLC invests in the US, United Kingdom and Europe.